Blog

Leveraging Conjoint Analysis for Informed Decision-Making

By: Leah Turner In an ever-evolving healthcare landscape, making informed decisions that cater to your policyholders' needs is paramount. As a health insurance provider, you are undoubtedly familiar with the complexities and challenges of the industry. This blog post explores a powerful tool that can assist you in this endeavor...

The Utilization of AI for Prior Authorization: Pros, Cons, and Consumer Perspectives

By: Leah Turner In the ever-evolving world of healthcare, prior authorizations have long been a cumbersome process, burdening both insurers and healthcare providers. Recent developments in artificial intelligence (AI) are disrupting this process, offering the promise of efficiency and cost reduction. In this blog post, we'll delve into general feelings...

Keeping up with Generation Jones

By Brandon Dunk On a day-to-day basis, demographic shifts are nearly unnoticeable. But in the long run, it’s also important to remember that demographics slowly shift the landscape much like a river. Hence the phrase, “Demography is destiny,” and its use as postmortem of those who failed while refusing to...

Explore Duals Plan Options with Our Simulator Tool

When you purchase either of our industry-leading Duals studies, you can now add on Deft’s powerful Dual Acquisition Simulator Tool for only $5,000 more. Our Dual Acquisition Simulator Tool is ideal for last-minute design checks. Use it to model supplemental benefit packages and purses based on nine areas examined in...

CMS’s HCC: A Medicare Battleground for Years to Come

By Brandon Dunk   CMS’s deadline for publishing its final rate announcement was April 3, 2023; in the end, it was able to release the information a little early on March 31st. Many of the worst fears of carriers were alleviated with the press release, where CMS expected the average...

Medicare Reimbursement Turmoil

by Brandon Dunk   Medicare Advantage carriers are counting down to April 3rd, and Deft Research is watching with them. April 3, 2023, is the date that CMS will publish its final rate announcement. These rates have already been previewed in the 2024 Medicare Advantage Prescription Drug (MAPD) Advance Notice,...